Liubchenko, Grigory https://orcid.org/0000-0001-8888-7272
Böning, Guido
Rumiantcev, Mikhail
Zounek, Adrian J.
Zacherl, Mathias J.
Sheikh, Gabriel
Resch, Sandra
Werner, Rudolf A.
Ziegler, Sibylle I.
Delker, Astrid
Funding for this research was provided by:
Klinikum der Universität München
Article History
Received: 19 May 2025
Accepted: 3 September 2025
First Online: 2 October 2025
Declarations
:
: This study was approved by the ethics committee of the medical faculty of LMU Munich (project no. 22–0544).
: Written consent to participate is not required as this study is based on retrospective and irreversibly anonymized data.
: Not required.
: Rudolf A. Werner performs advisory board work for Novartis/AAA and Bayer and is a speaker honoraria from Novartis/AAA and PentixaPharm.